U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
Raxorulimogene Belzovacirepvec
INN  
Official Name English
recombinant replication-competent oncolytic vaccinia virus (VACV; strain Copenhagen) encoding three codon-optimised transgenes: (i) anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) immunoglobulin G1 γ1-chain fused via a synthetic T2A peptide wi
Common Name English
raxorulimogene belzovacirepvec [INN]
Common Name English
Code System Code Type Description
FDA UNII
P3D8R5LG7H
Created by admin on Sat Dec 16 19:29:24 GMT 2023 , Edited by admin on Sat Dec 16 19:29:24 GMT 2023
PRIMARY
INN
12356
Created by admin on Sat Dec 16 19:29:24 GMT 2023 , Edited by admin on Sat Dec 16 19:29:24 GMT 2023
PRIMARY
CAS
2648343-10-4
Created by admin on Sat Dec 16 19:29:24 GMT 2023 , Edited by admin on Sat Dec 16 19:29:24 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966